VS

Venkata Satya Narayana Gopu

Active Director Director DIN 08676757
DIN 08676757 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Satya Narayana Gopu

Data last updated:

Venkata Satya Narayana Gopu is a Director at Fomed Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals.

DIN 08676757
Primary Designation Director
Industry Chemicals
First Appointment 23 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jan 20202020Active

Board colleagues of Venkata Satya Narayana Gopu

NameDINCompanyDesignation
Gopu Venkata Prasanth08676756Fomed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fomed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkata Satya Narayana Gopu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Satya Narayana Gopu

Venkata Satya Narayana Gopu currently holds 1 directorship: Fomed Pharmaceuticals Private Limited (Director, since 23 Jan 2020).

Venkata Satya Narayana Gopu was first appointed on 23 Jan 2020 as Director at Fomed Pharmaceuticals Private Limited.

The current boards of Venkata Satya Narayana Gopu's companies include Gopu Venkata Prasanth (Fomed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available